🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesMy blood pressure normalization journey — my results so far Page 3

My blood pressure normalization journey — my results so far

FranDenver Tue, Jan 9, 2024 at 7:38 AM 12 replies 2,127 viewsPage 3 of 3
BethLabQueen
Senior Member
1,234
5,678
May 2024
Virginia
Online
Jan 11, 2024 at 4:41 AM#11
andrew_nyc said:
Dr.PeteFamMed said: ...we don't know the long-term effects of cardiovascular risk...

Senior perspective on cardiovascular risk: I'm 63 years old and started this journey skeptically. My geriatrician recommended it after years of failed interventions.

9 months later: down 51 lbs, more mobile, pain reduced, medications simplified. My quality of life has improved dramatically. I wish this existed 20 years ago.

To other older adults hesitating: the SELECT trial proved benefit in our age group. You deserve to feel good in your body regardless of age.

Last edited: Jan 11, 2024 at 5:41 AM
19 17maya_sedona, stefan_berlin, Dr.EM_Chicago and 16 others
Reply Quote Save Share Report
tammy_FL
Member
234
890
Nov 2024
Tampa, FL
Jan 12, 2024 at 4:53 PM#12
cory_ATX said:
Positive "side effect" of cardiovascular risk: my blood pressure dropped so much that I'm now off losartan entirely!

Bookmarking. The distinction being drawn above is the one nobody else makes.

20 18alex_tucson, kevin_tulsa, Dr.PainCLE and 17 others
Reply Quote Save Share Report
kim_atl_prep
Member
312
1,345
Aug 2024
Atlanta, GA
Jan 14, 2024 at 5:04 AM#13
andrew_nyc said:
Dr.PeteFamMed said: ...we don't know the long-term effects of cardiovascular risk...

I'm 58 years old and want to share my perspective on cardiovascular risk as an older member of this community.

My doctor was initially hesitant because of my age, but the SELECT trial included patients up to 72 and showed consistent benefit across age groups. We started at the lowest dose with closer monitoring.

16 months later: down 63 lbs, off metoprolol, A1C from 8.6% to 5.2%. My cardiologist is thrilled. cardiovascular risk is absolutely relevant for older adults — don't let anyone tell you otherwise.

Last edited: Jan 14, 2024 at 11:04 AM
21 19RegAffairsDC, BiostatsBrad, PeptideSynthNJ and 18 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
TrialTracker_MD
Senior Member
2,345
15,678
Jan 2024
Maryland
Jan 15, 2024 at 5:14 PM#14
FranDenver said:
Prescribed on cardiovascular grounds rather than for weight, and almost everything written for patients assumes the opposite.
FranDenver said:
...we're creating a generation dependent on cardiovascular risk...

I understand the concern, but consider this analogy: are we "creating a generation dependent on" blood pressure medication? Cholesterol medication? Thyroid medication?

Obesity is a chronic disease with biological drivers. Treating it with medication is no different from treating any other chronic condition. The "dependency" framing implies weakness or moral failure — neither of which is accurate.

If ongoing medication is what keeps someone healthy, that's successful treatment, not dependency.

22 20Dr.PulmRoch, maya_sedona, stefan_berlin and 19 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Jan 17, 2024 at 5:24 AM#15

Moderator note: reminder that nothing in this thread is medical advice, and that clinical claims need a source. No action needed from anybody.

23 21PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 20 others
Reply Quote Save Share Report

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register